[{"country": "United States", "city": "Tampa", "address_1": "2631 Causeway Center Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Label indicates that the product contains Vitamin B12 (12 micrograms) on the Supplement Facts panel, however, the formulation of this product does not contain Vitamin B12.", "address_2": "", "product_quantity": "142,732 bottles", "code_info": "Lot #: 505024006, 505024007, Exp 03/15; 505024008; 505024009, Exp 06/15; 505024010, Exp 08/15; 505024011, Exp 09/15; and 505024012, Exp 10/15", "center_classification_date": "20140819", "distribution_pattern": "Nationwide", "state": "FL", "product_description": "Triveen - PRx RNF Capsules, 30-count bottles, Rx only; Manufactured for: Trigen Laboratories, Inc., Sayreville, NJ  08872, NDC 13811-558-30, UPC 3 13811 55830 2.", "report_date": "20140827", "classification": "Class III", "openfda": {}, "recalling_firm": "Trigen Laboratories, Inc.", "recall_number": "D-1544-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68685", "termination_date": "20170726", "more_code_info": "", "recall_initiation_date": "20140417", "postal_code": "33619-6102", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201845"], "brand_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "generic_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Jubilant Cadista Pharmacuticals Inc."], "product_ndc": ["59746-337", "59746-338", "59746-339"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "LOSARTAN POTASSIUM"], "rxcui": ["979464", "979468", "979471"], "spl_id": ["254a3da5-afd8-4a49-86d3-e347868cb906"], "spl_set_id": ["e0b74a86-3d36-1af0-e538-41b45b8d2cc3"], "package_ndc": ["59746-337-30", "59746-337-90", "59746-337-01", "59746-337-10", "59746-338-30", "59746-338-90", "59746-338-01", "59746-338-10", "59746-339-30", "59746-339-90", "59746-339-01", "59746-339-10"], "is_original_packager": [true], "upc": ["0359746339302", "0359746337308", "0359746338305"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "3ST302B24A"]}, "product_type": "Drugs", "event_id": "68776", "recalling_firm": "Jubilant Cadista Pharmaceuticals Inc.", "address_1": "207 Kiley Dr", "address_2": "", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1500-2014", "product_description": "Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 90-tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC # 59746-339-90", "product_quantity": "9,358 bottles", "reason_for_recall": "Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.", "recall_initiation_date": "20140711", "center_classification_date": "20140731", "termination_date": "20160915", "report_date": "20140806", "code_info": "Lot #14P0292, Exp 04/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Clive", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68626", "recalling_firm": "Medical Supply Liquidators Llc", "address_1": "10500 Hickman Rd Ste F", "address_2": "N/A", "postal_code": "50325-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.", "recall_number": "D-1528-2014", "product_description": "B Complex for Injection USP with Methylcobalamin 1000 mcg/ml, Sterile, for IM or Deep SQ use, multiple dose vial, packaged in 10 ml vials and 30 ml vials. Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us.", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer", "recall_initiation_date": "20140625", "center_classification_date": "20140806", "termination_date": "20170314", "report_date": "20140813", "code_info": "All lot numbers and exp dates"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx # 28838, Exp 03/4/15", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "ANA Kit, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 28838, Discard After 03/4/15", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1470-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68967", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1575-2014", "product_description": "PAXIL  (Paroxetine HCL) Oral Suspension 10 mg/5 mL - 250 mL bottle, Rx Only, Manufactured by GlaxoSmithKline, RTP, NC 27709. Distributed by Apotex Corp., Westin, FL 33326, NDC 60505-0402-5", "product_quantity": "13,429 bottles", "reason_for_recall": "Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.", "recall_initiation_date": "20140324", "center_classification_date": "20140903", "termination_date": "20140923", "report_date": "20140910", "code_info": "Lot # 2A001,  Exp. 01/15; Lot # 2C002, Exp. 03/15", "more_code_info": ""}, {"country": "United States", "city": "Conway", "address_1": "1270 Don's Lane", "reason_for_recall": "Labeling: Label Error on Declared Strength; The outer light protective bags, where the ephedrine sulfate injection syringes are stored, were mislabeled with 25 mg/mL in big font and 5 mg/mL in small font, however, the actual syringes were correctly labeled as 25 mg/5 mL.", "address_2": "", "product_quantity": "762 Syringes", "code_info": "Lot# 20142104@30  USE BY: 10/18/2014", "center_classification_date": "20140820", "distribution_pattern": "Nationwide", "state": "AR", "product_description": "ePHEDrine Sulfate Injection, USP 25 mg/5 mL (5 mg/mL)  Single Use 5 mL Syringe, For IV, IM, or SC injection, Preservative Free, For Office/Hospital Use Only, Protect from Light,  62295-3084-05, US Compounding Pharmacy, Conway, AR 800-718-3588", "report_date": "20140827", "classification": "Class II", "openfda": {}, "recalling_firm": "US Compounding Inc", "recall_number": "D-1548-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "68336", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20140516", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Clive", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68626", "recalling_firm": "Medical Supply Liquidators Llc", "address_1": "10500 Hickman Rd Ste F", "address_2": "N/A", "postal_code": "50325-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.", "recall_number": "D-1525-2014", "product_description": "MIC Injection USP, Sterile, 10 ml vial and 30 ml vial, For IM or Deep SQ Use, Multiple Dose Vial, Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer", "recall_initiation_date": "20140625", "center_classification_date": "20140806", "termination_date": "20170314", "report_date": "20140813", "code_info": "All lot numbers and exp dates"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA011757"], "brand_name": ["DEPO-MEDROL"], "generic_name": ["METHYLPREDNISOLONE ACETATE"], "manufacturer_name": ["Pharmacia & Upjohn Company LLC"], "product_ndc": ["0009-3073", "0009-3475"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRA-ARTICULAR", "INTRALESIONAL", "INTRAMUSCULAR", "SOFT TISSUE", "INTRASYNOVIAL"], "substance_name": ["METHYLPREDNISOLONE ACETATE"], "rxcui": ["1743779", "1743781", "1743855", "1743856"], "spl_id": ["befd723e-d1e2-41b9-83f1-17bca0c2a941", "bdefc300-8d7c-474c-9771-200628f25035"], "spl_set_id": ["9a7b3837-e038-48bf-97e9-78ad463760dc", "bf1b104d-85cb-414d-a366-78068c82c883"], "package_ndc": ["0009-3073-01", "0009-3073-03", "0009-3475-01", "0009-3475-03", "0009-3073-22", "0009-3073-23", "0009-3475-22", "0009-3475-23"], "is_original_packager": [true], "upc": ["0300093073036"], "unii": ["43502P7F0P"]}, "product_type": "Drugs", "event_id": "68876", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1537-2014", "product_description": "Depo-Medrol (methylprednisolone acetate injectable suspension USP), 40 mg/ mL, 1 mL Single-Dose Vial, Rx only, Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, New York NY 10017  NDC 0009-3073-03    DEPO-MEDROL methylprednisolone acetate Injectable Suspension USP, 40 mg per mL,  1 mL Single-Dose Vial, Rx ONLY, Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, New York NY 10017, NOVAPLUS is a registered trademark of Novation, LLC NDC 0009-3073-23", "product_quantity": "93,800 vials", "reason_for_recall": "Failed pH Specification: A pH result of 2.9 was obtained at the 9 month stability test interval at 25C/60%RH. The registered specification for pH is 3.0 - 7.0", "recall_initiation_date": "20140730", "center_classification_date": "20140812", "termination_date": "20170322", "report_date": "20140820", "code_info": "Lot  H43272,  H43265 Exp. 09/14"}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "68787", "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)", "address_1": "1718 Northrock Ct", "address_2": "N/A", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, and Guam.", "recall_number": "D-1435-2014", "product_description": "Diltiazem HCl Extended-release Capsules, USP, 120 mg, packaged in 80 Capsules (8 x 10) blister cards per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV  26505, NDC 51079-947-08.", "product_quantity": "1,184 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.", "recall_initiation_date": "20140703", "center_classification_date": "20140717", "termination_date": "20160726", "report_date": "20140723", "code_info": "Lot #: 3045659, 3048256, Exp 07/14"}, {"status": "Terminated", "city": "Owens Cross Roads", "state": "AL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "68671", "recalling_firm": "Poly Pharmaceuticals, Inc", "address_1": "2720 Cullom Blvd Se", "address_2": "N/A", "postal_code": "35763-9309", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1431-2014", "product_description": "POLY-TUSSIN AC LIQUID, Each 5 mL (1 teaspoonful) contains: Brompheniramine Maleate 4 mg, Codeine Phosphate 10 mg, Phenylephrine HCl 7.5 mg, 16 fl oz. (473 mL) Bottle, Rx Only. Manufactured by: Great Southern Laboratories, Houston, TX 77099, Distributed for: Poly Pharmaceuticals, Mobile, AL  36619. NDC: 50991-713-16.", "product_quantity": "208 Bottles", "reason_for_recall": "Does Not Meet Monograph: Phenylephrine and pseudoephedrine are below monograph specifications, and label inaccurately contains wording \"Rx Only\".", "recall_initiation_date": "20140626", "center_classification_date": "20140711", "termination_date": "20141103", "report_date": "20140723", "code_info": "Lot #: 04413, Expiry: 02/15"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68967", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1581-2014", "product_description": "PAXIL (Paroxetine HCL) Tablets 20 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3664-3", "product_quantity": "", "reason_for_recall": "Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.", "recall_initiation_date": "20140324", "center_classification_date": "20140903", "termination_date": "20140923", "report_date": "20140910", "code_info": "Lot # 2ZP5499, Exp. 02/15", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "8 units", "code_info": "Rx # 29096, Exp 05/20/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Cubicin 600 mg/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29096, Discard After 05/20/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1477-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "21 units", "code_info": "Rx #28694, Exp 05/22/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Impipenem/Cilastin (Primaxin) 500 mg/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx #28694, Discard After 05/22/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1465-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "La Mirada", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68122", "recalling_firm": "Sung Soo Kim", "address_1": "14747 Artesia Blvd # 5c", "address_2": "N/A", "postal_code": "90638-6008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US nationwide and Korea", "recall_number": "D-1535-2014", "product_description": "Super ARTHGOLD 500mg, 120 Capsule Bottle, Dietary Supplement.  Manufactured for & Distributed by Nanowellbeing Health, Inc., 14747 Artesia Blvd, #5V, La Mirada, CA 90638.  UPC: 7 99475 35350 5.", "product_quantity": "6,336 bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA; Product contains undeclared indomethacin, diclofenac, and chlorzoxazone.", "recall_initiation_date": "20140415", "center_classification_date": "20140808", "termination_date": "20140922", "report_date": "20140820", "code_info": "Lot #:  L1P1-6100 (expiry 6/25/2016) and L1P2-6000 (expiry 9/16/2016)."}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "Rx # 28839, Exp 05/5/15; Rx # 29136, Exp 05/8/15", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Normal Saline 10 mL/10 mL Syringe, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, Rx # 28839, Discard After 05/5/15; Rx # 29163, Discard After 05/8/15", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1468-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx 28314 Exp 5/22/2014", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Desferal 2.5 gm/14 mL Sterile Water, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, Rx # 28314, Discard After 05/22/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1456-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA040327"], "brand_name": ["ORPHENADRINE CITRATE"], "generic_name": ["ORPHENADRINE CITRATE"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0185-0022"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ORPHENADRINE CITRATE"], "rxcui": ["994521"], "spl_id": ["de0e8cdb-788a-4ebe-969d-14d44a14ddc2"], "spl_set_id": ["239018ff-cec6-46de-ae9d-26c9ec034a32"], "package_ndc": ["0185-0022-10", "0185-0022-01"], "is_original_packager": [true], "unii": ["X0A40N8I4S"]}, "product_type": "Drugs", "event_id": "68860", "recalling_firm": "Sandoz Inc", "address_1": "506 Carnegie Ctr", "address_2": "", "postal_code": "08540-6243", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1445-2014", "product_description": "Orphenadrine Citrate Extended Release Tablets, 100 mg  a)100-count bottle,  (NDC 0185-0022-01) b) 1000-count bottle, (NDC 0185-0022-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540.", "product_quantity": "781,000 extended release tablets", "reason_for_recall": "Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.", "recall_initiation_date": "20140711", "center_classification_date": "20140723", "termination_date": "20170710", "report_date": "20140730", "code_info": "Lot # DM1316; Exp.  05/16  Lot # DM1318; Exp.  05/16", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {"application_number": ["NDA020936"], "brand_name": ["PAROXETINE HYDROCHLORIDE"], "generic_name": ["PAROXETINE HYDROCHLORIDE"], "manufacturer_name": ["Apotex Corp"], "product_ndc": ["60505-1316", "60505-1317", "60505-1318", "60505-3673", "60505-3674", "60505-3675"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PAROXETINE HYDROCHLORIDE"], "rxcui": ["1738803", "1738805", "1738807"], "spl_id": ["f641c7b3-f7d2-9446-e589-074ac368853a"], "spl_set_id": ["087ff0d3-1761-47ea-a8c1-7c4cb679af97"], "package_ndc": ["60505-1316-3", "60505-1317-3", "60505-1318-3", "60505-3673-3", "60505-3674-3", "60505-3675-3"], "is_original_packager": [true], "upc": ["0360505367436", "0360505367535", "0360505367337"], "unii": ["X2ELS050D8"]}, "product_type": "Drugs", "event_id": "68967", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1574-2014", "product_description": "Paroxetine HCL Controlled-Release Tablets 12.5 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3673-3", "product_quantity": "", "reason_for_recall": "Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.", "recall_initiation_date": "20140324", "center_classification_date": "20140903", "termination_date": "20140923", "report_date": "20140910", "code_info": "Lot # 2A001, Exp. 01/15  Lot # 2A002, Exp. 01/15  Lot # 2C003, Exp. 03/15  Lot # 2F005, Exp. 06/15  Lot # 2G006, Exp. 07/15", "more_code_info": ""}, {"country": "United States", "city": "Oklahoma City", "address_1": "755 Research Pkwy Ste 150", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.", "address_2": "", "product_quantity": "", "code_info": "all lot codes 30 ml and 50 ml", "center_classification_date": "20140729", "distribution_pattern": "Nationwide", "state": "OK", "product_description": "Therametics Complexion Repair Topical Rehydrating Emulsion in 50 ml and 30 ml containers in the Complexion Repair Acne Treatment System Kit and the Complexion Repair Acne Travel Kit with SKU numbers of CR1005 and CR1007, respectively.", "report_date": "20140806", "classification": "Class II", "openfda": {}, "recalling_firm": "Dermamedics, L.L.C.", "recall_number": "D-1495-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67247", "termination_date": "20170314", "more_code_info": "", "recall_initiation_date": "20140110", "postal_code": "73104-3621", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx 29184 Exp 5/28/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Levofloxacin 750 mg/250 mL D5W, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx #29184, Discard After 05/28/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1453-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Suite 200", "reason_for_recall": "Lack of Assurance of Sterility: Firm received fentanyl from a supplier who recalled it  because fliptop vial crimps were loose or missing.", "address_2": "", "product_quantity": "220 syringes", "code_info": "Lots 7083-0, 7202-0, 7222-0 Exp. 08/14", "center_classification_date": "20140821", "distribution_pattern": "Texas and Georgia", "state": "TX", "product_description": "fentaNYL 2750 mcg/55 mL (50 mcg/mL) in prefilled syringe, COMPOUNDED DRUG,   For Institutional or Office Use Only--Not for Resale   Federal Law Prohibits Dispensing without Prescription  Healix Infusion Therapy, Inc.  (866) 298-4826 1075 West Park One Drive, Suite 200, Sugar Land, Texas, 77478  NDC  75901-8008-33", "report_date": "20140827", "classification": "Class II", "openfda": {}, "recalling_firm": "Healix Infusion Therapy, Inc.", "recall_number": "D-1554-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "69056", "termination_date": "20150825", "more_code_info": "", "recall_initiation_date": "20140627", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Clive", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68626", "recalling_firm": "Medical Supply Liquidators Llc", "address_1": "10500 Hickman Rd Ste F", "address_2": "N/A", "postal_code": "50325-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.", "recall_number": "D-1522-2014", "product_description": "Vitamin B12 Cyanocobalamin Injection USP 1000 mcg/ml, Sterile, 10 ml vial and 30 ml vial, For IM or Deep SQ Use, Multiple Dose Vial, Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer", "recall_initiation_date": "20140625", "center_classification_date": "20140806", "termination_date": "20170314", "report_date": "20140813", "code_info": "All lot numbers and exp dates"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076242"], "brand_name": ["CALCITRIOL"], "generic_name": ["CALCITRIOL"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0054-3120"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CALCITRIOL"], "rxcui": ["313932"], "spl_id": ["2b8745f3-5289-474e-bd44-48b59a40dd78"], "spl_set_id": ["3289b482-8733-484d-b1db-d7f4cdcd1ac2"], "package_ndc": ["0054-3120-41"], "is_original_packager": [true], "nui": ["M0004229", "N0000175908"], "pharm_class_cs": ["Cholecalciferol [CS]"], "pharm_class_epc": ["Vitamin D3 Analog [EPC]"], "unii": ["FXC9231JVH"]}, "product_type": "Drugs", "event_id": "68389", "recalling_firm": "Boehringer Ingelheim Roxane Inc", "address_1": "1809 Wilson Rd", "address_2": "", "postal_code": "43228-9579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide", "recall_number": "D-1427-2014", "product_description": "Calcitriol Oral Solution 1 mcg/mL, 15mL bottle, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-3120-41.", "product_quantity": "5364 bottles", "reason_for_recall": "Failed Impurity/Degradation Specification; out of specification for trans-calcitriol degradant at the 9 month stability time point", "recall_initiation_date": "20140501", "center_classification_date": "20140709", "termination_date": "20150401", "report_date": "20140716", "code_info": "Lot # 360122A, EXP Date: MAY 2015", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx # 29114, Exp 05/13/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Cubicin 444 mg/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29114, Discard After 05/13/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1467-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68348", "recalling_firm": "Bausch & Lomb, Inc.", "address_1": "8500 Hidden River Pkwy", "address_2": "N/A", "postal_code": "33637-1014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, Canada, and Hong Kong.", "recall_number": "D-1411-2014", "product_description": "Sodium Chloride Hypertonicity Ophthalmic Ointment, 5%, 1/8 oz. (3.5 g) tube per carton, Distributed by Major Pharmaceuticals, 31778 Enterprise Drive, Livonia, MI  48150, NDC 0904-5315-38, UPC 3 09045 31538 5.", "product_quantity": "35,253 tubes", "reason_for_recall": "Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye.", "recall_initiation_date": "20140410", "center_classification_date": "20140625", "termination_date": "20170414", "report_date": "20140702", "code_info": "Lot #'s: 159101, Exp 02/15; 169271, Exp 09/15; and 170481, Exp 10/15"}, {"country": "United States", "city": "New York", "address_1": "767 5th Ave Fl 47th", "reason_for_recall": "Stability Data Does Not Support Expiry", "address_2": "", "product_quantity": "3,791 tubes", "code_info": "All lot codes and shipment dates are being recalled. 2.6oz/75ml. in a light green carton, UPC: 8-82381-07901-7 Code: D079-01-1000", "center_classification_date": "20140724", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "DENBLAN Anticavity Fluoride Toothpaste, Whitening formula, sodium monofluorophosphate 0.76%, 2.6 oz/75 mL tube, Laboratories Darphin, Dist, Paris France", "report_date": "20140730", "classification": "Class III", "openfda": {}, "recalling_firm": "Estee Lauder Inc", "recall_number": "D-1452-2014", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "68449", "termination_date": "20151119", "more_code_info": "", "recall_initiation_date": "20140606", "postal_code": "10153-0023", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "5 units", "code_info": "Rx 29162 Exp. 5/21/2014", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Nafcillin 12 gm/300 mL, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29162, Discard After 05/21/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1462-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040361"], "brand_name": ["DEXTROAMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SULFATE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-0952", "0555-0953"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DEXTROAMPHETAMINE SULFATE"], "rxcui": ["884385", "884386"], "spl_id": ["e339af0f-084a-4d19-8013-3ccb826816d0"], "spl_set_id": ["ec2d13f3-d14f-47e4-abe9-7763f95a8e94"], "package_ndc": ["0555-0952-02", "0555-0953-02"], "is_original_packager": [true], "unii": ["JJ768O327N"]}, "product_type": "Drugs", "event_id": "68225", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "N/A", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1408-2014", "product_description": "Dextroamphetamine Sulfate Tablets, USP, 10 mg, 100-count bottles, Rx only, Barr Laboratories, Inc., Pomona, NY 10970, NDC 0555-0953-02.", "product_quantity": "9,882 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing.", "recall_initiation_date": "20140501", "center_classification_date": "20140623", "termination_date": "20141209", "report_date": "20140702", "code_info": "Lot # 34013122A, Exp 11/15"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021992"], "brand_name": ["PRISTIQ"], "generic_name": ["DESVENLAFAXINE SUCCINATE"], "manufacturer_name": ["Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."], "product_ndc": ["0008-1210", "0008-1211", "0008-1222"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DESVENLAFAXINE SUCCINATE"], "rxcui": ["790267", "790290", "1607617", "1607619", "1874553", "1874559"], "spl_id": ["1bdeb7f1-3871-48b2-9fa9-7fdb714faf3f"], "spl_set_id": ["0f43610c-f290-46ea-d186-4f998ed99fce"], "package_ndc": ["0008-1211-50", "0008-1211-01", "0008-1211-14", "0008-1211-30", "0008-1222-01", "0008-1222-14", "0008-1222-30", "0008-1222-50", "0008-1210-30"], "is_original_packager": [true], "upc": ["0300081210306", "0300081222309", "0300081211303"], "unii": ["ZB22ENF0XR"]}, "product_type": "Drugs", "event_id": "68001", "recalling_firm": "Pfizer Us Pharmaceutical Group", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1409-2014", "product_description": "Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc.,  NDC 0008-1211-30", "product_quantity": "220,761 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.", "recall_initiation_date": "20140416", "center_classification_date": "20140624", "termination_date": "20160920", "report_date": "20140702", "code_info": "H74477, H74478, Exp. 03/16,  H74479, H79766 Exp. 05/16"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019386"], "brand_name": ["BREVIBLOC"], "generic_name": ["ESMOLOL HYDROCHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["10019-055", "10019-115", "10019-075"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ESMOLOL HYDROCHLORIDE"], "rxcui": ["979432", "979434", "1736541", "1736543", "1736546", "1736547"], "spl_id": ["ff209fbb-f087-4772-8945-9b1ab9a8c3a2"], "spl_set_id": ["595cc3d5-1306-4828-aefa-5595219ffd62"], "package_ndc": ["10019-115-39", "10019-115-01", "10019-075-87", "10019-055-61"], "is_original_packager": [true], "unii": ["V05260LC8D"]}, "product_type": "Drugs", "event_id": "68577", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1413-2014", "product_description": "Brevibloc Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2,500 mg/250 mL (10 mg/mL), 250 mL Single Use IntraVia container, packaged in 10 x 250 mL Single Use IntraVia containers per carton, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product Code 2J1415, NDC 10019-055-61.", "product_quantity": "20,810 containers", "reason_for_recall": "Presence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating.", "recall_initiation_date": "20140616", "center_classification_date": "20140701", "termination_date": "20170410", "report_date": "20140709", "code_info": "Lot #: C926923, Exp 01/16", "more_code_info": ""}, {"country": "United States", "city": "San Clemente", "address_1": "197 Avenida La Pata", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA analysis discovered undeclared lovastatin, making this an unapproved new drug.", "address_2": "", "product_quantity": "7,379 bottles", "code_info": "Lot # 3121005; Exp 02/17", "center_classification_date": "20140820", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "Doctor'\u0019s Best  Red Yeast Rice 1200, 600 mg Capsules, 120-count bottle. UPC 753950001183, Manufactured for Doctor's Best San Clemente, CA 92673", "report_date": "20140827", "classification": "Class II", "openfda": {}, "recalling_firm": "Doctor's Best, Inc.", "recall_number": "D-1549-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "68638", "termination_date": "20141021", "more_code_info": "", "recall_initiation_date": "20140624", "postal_code": "92673-6307", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Huntsville", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69157", "recalling_firm": "Qualitest Pharmaceuticals", "address_1": "120 Vintage Dr NE", "address_2": "", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1572-2014", "product_description": "OXYCODONE and ACETAMINOPHEN, USP 10 mg/325 mg, CII, 100 TABLETS, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-4982-21", "product_quantity": "23,544 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Broken tablets found in sealed bottles.", "recall_initiation_date": "20140827", "center_classification_date": "20140903", "termination_date": "20160201", "report_date": "20140910", "code_info": "T062A14A, Exp 12/15", "more_code_info": ""}, {"country": "United States", "city": "Earth City", "address_1": "13600 Shoreline Dr", "reason_for_recall": "Failed Dissolution Specifications: Drug failed stage III dissolution testing.", "address_2": "", "product_quantity": "92,544 Bottles", "code_info": "Lot # A308879, Expiry: 09/2015", "center_classification_date": "20140630", "distribution_pattern": "Nationwide including Puerto Rico.", "state": "MO", "product_description": "Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only.  Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, Missouri 63045. NDC 0456-1420-07.", "report_date": "20140709", "classification": "Class II", "openfda": {}, "recalling_firm": "Forest Pharmaceuticals Inc", "recall_number": "D-1412-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "68548", "termination_date": "20160105", "more_code_info": "", "recall_initiation_date": "20140619", "postal_code": "63045", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Clive", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68626", "recalling_firm": "Medical Supply Liquidators Llc", "address_1": "10500 Hickman Rd Ste F", "address_2": "N/A", "postal_code": "50325-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.", "recall_number": "D-1519-2014", "product_description": "Vitamin B12 Methylcobalamin with MIC Injection USP 1000 mcg/ml, Sterile, 10 ml vial and 30 ml vial. For IM or Deep SQ Use, Multiple Dose Vial.  Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer", "recall_initiation_date": "20140625", "center_classification_date": "20140806", "termination_date": "20170314", "report_date": "20140813", "code_info": "All lot numbers and exp dates"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA040301"], "brand_name": ["WARFARIN SODIUM"], "generic_name": ["WARFARIN SODIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-4027", "51672-4028", "51672-4029", "51672-4030", "51672-4031", "51672-4032", "51672-4033", "51672-4034", "51672-4035"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["WARFARIN SODIUM"], "rxcui": ["855288", "855296", "855302", "855312", "855318", "855324", "855332", "855338", "855344"], "spl_id": ["373f3fe2-c159-028e-e063-6394a90aff59"], "spl_set_id": ["8ad881e0-ca41-42ad-9d7d-eb85b3a30af0"], "package_ndc": ["51672-4027-1", "51672-4027-3", "51672-4027-7", "51672-4027-0", "51672-4028-1", "51672-4028-3", "51672-4028-7", "51672-4028-0", "51672-4029-1", "51672-4029-3", "51672-4029-7", "51672-4029-0", "51672-4030-1", "51672-4030-3", "51672-4030-7", "51672-4030-0", "51672-4031-1", "51672-4031-3", "51672-4031-7", "51672-4031-0", "51672-4032-1", "51672-4032-3", "51672-4032-7", "51672-4032-0", "51672-4033-1", "51672-4033-3", "51672-4033-7", "51672-4033-0", "51672-4034-1", "51672-4034-3", "51672-4034-0", "51672-4035-1", "51672-4035-3", "51672-4035-0"], "is_original_packager": [true], "upc": ["0351672402815", "0351672403416", "0351672402914", "0351672403119", "0351672403218", "0351672403010", "0351672403515", "0351672403317"], "unii": ["6153CWM0CL"]}, "product_type": "Drugs", "event_id": "69075", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "N/A", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including: OH, HI, NH, MS, IL, TX, CA.", "recall_number": "D-1584-2014", "product_description": "Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only. Mfd. by: Taro Pharmaceutical Industries, Ltd.,  Haifa Bay, Israel 26110.  Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. 100 Tablet Bottle NDC: 51672-4028-1, 1000 Tablet Bottle NDC: 51672-4028-3.", "product_quantity": "1396 Bottles", "reason_for_recall": "Failed Content Uniformity Specifications.", "recall_initiation_date": "20140825", "center_classification_date": "20140912", "termination_date": "20180518", "report_date": "20140924", "code_info": "Lot #: 149400, Expiry: January 2016;   Lot #: 149649, Expiry: January 2016.", "more_code_info": ""}, {"country": "United States", "city": "Lewis Center", "address_1": "741 Radio Dr", "reason_for_recall": "Labeling: Label Mix Up; packages labeled as Thiamine actually contain Diltiazem Capsules", "address_2": "", "product_quantity": "89/120 mg tablets", "code_info": "Use By: 5/31/2013, Lot: 0021OC, NDC 62037-0696-90", "center_classification_date": "20140723", "distribution_pattern": "Product was shipped to the following states: CO, MA, OH, TX & WY.", "state": "OH", "product_description": "Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine.  Re-Packaged By: Shamrock Medical Solutions, Lewis Center, Ohio, Mfg: Watson Laboratories, Corona, CA   NDC 62037-0696-90", "report_date": "20140730", "classification": "Class I", "openfda": {}, "recalling_firm": "Shamrock Medical Solutions Group LLC", "recall_number": "D-1446-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "64611", "termination_date": "20140731", "more_code_info": "", "recall_initiation_date": "20110927", "postal_code": "43035-7134", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx # 29083, Exp 05/21/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Cubicin 700 mg/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29083, Discard After 05/21/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1478-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Telford", "address_1": "306 Keystone Dr", "reason_for_recall": "Marketed without an Approved NDA/ANDA; product is being manufactured and distributed without a NDC number", "address_2": "Unit B", "product_quantity": "20,369 bottles", "code_info": "G12069 July 2014  H12087 August 2014  H12089 August 2014  L12161 December 2014  D13076 April 2015  G13120 July 2015  I13145 September 2015  J13165 October 2015  J13166 October 2015", "center_classification_date": "20140715", "distribution_pattern": "Nationwide", "state": "PA", "product_description": "Hemo-Stat Solution, Aluminum chloride 25%, in 37.2 g glass bottles, distributed by Benco Dental, Pittston, PA; Also distributed by Henry Shein, Melville, NY; and Hemoban distributed by iSmile Dental Products, Sacramento, CA", "report_date": "20140723", "classification": "Class II", "openfda": {}, "recalling_firm": "Axcentria Pharmaceuticals, LLC", "recall_number": "D-1434-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "68481", "termination_date": "20161128", "recall_initiation_date": "20140505", "postal_code": "18969", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Edison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68793", "recalling_firm": "Daiichi Sankyo Pharma Development", "address_1": "399 Thornall St", "address_2": "", "postal_code": "08837-2236", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1503-2014", "product_description": "Benicar HCT Tablets (olmesartan medoxomil, hydrochlorothiazide) 20 mg/12.5 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-105-30", "product_quantity": "108 bottles", "reason_for_recall": "Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping", "recall_initiation_date": "20140712", "center_classification_date": "20140731", "termination_date": "20150316", "report_date": "20140806", "code_info": "Lot #0002106  Exp - 11/30/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Cary", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M016"], "brand_name": ["COMFORT SHIELD BARRIER"], "generic_name": ["DIMETHICONE"], "manufacturer_name": ["Sage Products LLC"], "product_ndc": ["53462-915"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["DIMETHICONE"], "rxcui": ["968663", "1088604"], "spl_id": ["419e18cd-fa52-b78d-e063-6294a90a467c"], "spl_set_id": ["cc08f571-84ae-4c2f-b09d-a83a8efc39f5"], "package_ndc": ["53462-915-50", "53462-915-51", "53462-915-62", "53462-915-80", "53462-915-81", "53462-915-24", "53462-915-60"], "is_original_packager": [true], "nui": ["N0000010282"], "pharm_class_pe": ["Skin Barrier Activity [PE]"], "unii": ["92RU3N3Y1O"]}, "product_type": "Drugs", "event_id": "69141", "recalling_firm": "Sage Products Inc", "address_1": "3909 3 Oaks Rd", "address_2": "", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1573-2014", "product_description": "Comfort Shield Barrier Cream Cloths with dimethicone a) 8 count NDC 53462-915-80, b) 24 count NDC 53462-915-60, OTC, SAGE PRODUCTS INC., 3909 Three Oaks Road, Cary, IL 60013", "product_quantity": "8-ct. 7,066 cases; 24-ct. 2,664 cases", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Comfort Shield Barrier Cream Cloth packages tested positive for bacterial contamination.", "recall_initiation_date": "20140827", "center_classification_date": "20140903", "termination_date": "20160208", "report_date": "20140910", "code_info": "Lot: 44385; Exp.06/16; Lot: 44669; Exp.12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Detroit", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68786", "recalling_firm": "Caraco Pharmaceutical Laboratories, Ltd.", "address_1": "1150 Elijah McCoy Dr", "address_2": "N/A", "postal_code": "48202-3344", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1510-2014", "product_description": "Cephalexin Capsules, USP, 250 mg, packaged in a) 100-count bottles (NDC 62756-293-88) and b) 500-count bottles (NDC 62756-293-13), Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., Acme Plaza, Andheri-Kurla Road, Andheri (East), Mumbai-400 059, India.", "product_quantity": "a) 70,152 bottles; b) 43,525 bottles", "reason_for_recall": "CGMP Deviations: These products are being recalled because they were manufactured with active pharmaceutical ingredients (APIs) that were not manufactured with good manufacturing practices.", "recall_initiation_date": "20140626", "center_classification_date": "20140801", "termination_date": "20150309", "report_date": "20140813", "code_info": "Lot #: a) AGL0098B, AGL0099B, AGL0100B, AGL0101B, Exp 09/14; AGM0073B, AGM0074B, Exp 04/15; AGM0125B, AGM0126B, Exp 07/15; AGM0158B, Exp 09/15; b) AGL0092A, AGL0093A, AGL0094A, AGL0095A,  AGL0096A, AGL0097A, AGL0102A, AGL0103A, AGL0104A, AGL0105A, Exp 09/14; AGM0067A, AGM0068A, AGM0069A, Exp 03/15; AGM0070A, AGM0071A, AGM0072A, AGM0085A, AGM0086A, Exp 04/15; AGM0127A, AGM0128A, AGM0129A, AGM0130A, AGM0131A, AGM0132A, Exp 07/15"}, {"country": "United States", "city": "Randolph", "address_1": "540 Route Ten West", "reason_for_recall": "Non-Sterility: Pharmacy Creations is recalling Ascorbic Acid 500 mg/mL 50 mL vials due to mold contamination.", "address_2": "", "product_quantity": "70 vials", "code_info": "Lot: 06062014@8, Do Not Use Beyond 12/03/2014", "center_classification_date": "20140819", "distribution_pattern": "NY, NJ, and Puerto Rico", "state": "NJ", "product_description": "Ascorbic Acid 500 mg/mL Sterile Injection, 50 mL Multi-dose Vial, Rx only, Pharmacy Creations, Randolph, NJ 07869.", "report_date": "20140827", "classification": "Class I", "openfda": {}, "recalling_firm": "Pharmacy Creations", "recall_number": "D-1546-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "68669", "termination_date": "20160919", "more_code_info": "", "recall_initiation_date": "20140625", "postal_code": "07869", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["MURO 128"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Bausch & Lomb Incorporated"], "product_ndc": ["24208-385"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1298435", "1299626"], "spl_id": ["22f5a4ba-407c-faf9-e063-6394a90a17a5"], "spl_set_id": ["93fafa27-5031-4d95-b4b8-5574b7204ae2"], "package_ndc": ["24208-385-55", "24208-385-56", "24208-385-01"], "is_original_packager": [true], "upc": ["0324208385562", "324208385012", "324208385555"], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "68348", "recalling_firm": "Bausch & Lomb, Inc.", "address_1": "8500 Hidden River Pkwy", "address_2": "N/A", "postal_code": "33637-1014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, Canada, and Hong Kong.", "recall_number": "D-1410-2014", "product_description": "Muro 128 (sodium chloride) hypertonicity ophthalmic ointment, 5%, packaged in a) 1 g tube per carton, professional sample, NDC 24208-385-01, UPC 3 24208-385-01 2; b) 1/8 oz. (3.5 g) tube per carton, NDC 24208-385-55, UPC 3 24208-385-55 5; and c) 1/4 oz. (7 g) Twin Pack, Two 1/8 oz. (3.5 g) tubes per carton, NDC 24208-385-56, UPC 3 24208-385-56 3; Bausch & Lomb Incorporated, Tampa, FL  33637.", "product_quantity": "a) 4,165 tubes; b) and c) 844,879 tubes", "reason_for_recall": "Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye.", "recall_initiation_date": "20140410", "center_classification_date": "20140625", "termination_date": "20170414", "report_date": "20140702", "code_info": "Lot #: a) 179271, Exp 08/14; b) and c) 146791, 146932, Exp 06/14; 151221, 151922, Exp 09/14; 159102, Exp 02/15; 160912, Exp 03/15; 162422, Exp 04/15; 163641, 05/15; 166592, Exp 07/15; 169273, Exp 09/15; 170482, Exp 10/15; 174882, Exp 12/15; 176932, Exp 01/16; 179272, Exp 02/16; 182772, Exp 05/16; 186722, Exp 07/16; 190182, Exp 09/16; and 191631, Exp 10/16"}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68532", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "37497 Schoolcraft Rd", "address_2": "N/A", "postal_code": "48150-1007", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Michigan and Wisconsin", "recall_number": "D-1559-2014", "product_description": "PEDIATRIC CARDIOPLEGIA, 255 mL, Rx Only, Central Admixture Pharmacy Services, Inc., Livonia, MI 48150", "product_quantity": "1 dose", "reason_for_recall": "Non Sterility; microbial contamination identified as Aspergillus species", "recall_initiation_date": "20140528", "center_classification_date": "20140825", "termination_date": "20140919", "report_date": "20140903", "code_info": "Lot # 13-920741-0-1 EXP 21 JUN 2014"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "24 units", "code_info": "Rx # 28288, Exp 02/4/14; Rx # 29176, Exp 05/21/14; Rx # 28829, Exp 05/17/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Cefepime 2 gm/100 mL D5W, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 28288, Discard After 02/4/14; Rx # 29176, Discard After 05/21/14; Rx # 28829, Discard After 05/17/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1457-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Oklahoma City", "address_1": "755 Research Pkwy Ste 150", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.", "address_2": "", "product_quantity": "unknown", "code_info": "all lot codes, .25 oz and 2 oz sizes", "center_classification_date": "20140729", "distribution_pattern": "Nationwide", "state": "OK", "product_description": "Dermamedics Calm & Correct Cream in 2 oz. containers with SKU number DM1020.", "report_date": "20140806", "classification": "Class II", "openfda": {}, "recalling_firm": "Dermamedics, L.L.C.", "recall_number": "D-1488-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67247", "termination_date": "20170314", "more_code_info": "", "recall_initiation_date": "20140110", "postal_code": "73104-3621", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67135", "recalling_firm": "Abrams Royal Pharamacy", "address_1": "8220 Abrams Rd", "address_2": "N/A", "postal_code": "75231-1402", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and to Canada", "recall_number": "D-1563-2014", "product_description": "MINERAL IV Injection, compounded by Abrams Royal Pharmacy, Inc., Dallas, TX", "product_quantity": "74", "reason_for_recall": "Non-Sterility; analytical results found product to contain Sphingomonas paucimobilis", "recall_initiation_date": "20131219", "center_classification_date": "20140825", "termination_date": "20161007", "report_date": "20140903", "code_info": "Lot number 11142013@74"}, {"status": "Terminated", "city": "Clive", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68626", "recalling_firm": "Medical Supply Liquidators Llc", "address_1": "10500 Hickman Rd Ste F", "address_2": "N/A", "postal_code": "50325-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.", "recall_number": "D-1527-2014", "product_description": "Vitamin B12 Cyanocobalamin with MIC Injection USP 1000 mcg/ml, packaged in 10 ml vials and 30 ml vials, Sterile, for IM or Deep SQ Use, Multiple Dose Vial,  Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us.", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer", "recall_initiation_date": "20140625", "center_classification_date": "20140806", "termination_date": "20170314", "report_date": "20140813", "code_info": "All lot numbers and exp dates"}, {"country": "United States", "city": "Brookfield", "address_1": "19035 W. Capitol Dr", "reason_for_recall": "Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.", "address_2": "Suite 105", "product_quantity": "55 mL", "code_info": "Lot # / Beyond Use Date: 04232014@49 / BUD 06-22-14; 04232014@2 / BUD 06/22/14; 04252014@27 / BUD 06/24/14; 04162014@33 / BUD06/15/14; 05132014@2 / BUD 07/12/14; 05092014@39  BUD 7-8-14", "center_classification_date": "20140703", "distribution_pattern": "WI only", "state": "WI", "product_description": "HCG (Human Chorionic Gonadotropin) 200 units/ 0.1 mL drops, packaged in 5 mL and 10 mL bottles, Rx only, MD Custom Rx, 19035 W. Capitol Dr., Ste. 105, Brookfield, WI  53045", "report_date": "20140709", "classification": "Class II", "openfda": {}, "recalling_firm": "Brookfield Prescription Center Inc. dba MD Custom Rx", "recall_number": "D-1420-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "68616", "termination_date": "20150522", "more_code_info": "", "recall_initiation_date": "20140530", "postal_code": "53045", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Noblesville", "state": "IN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68191", "recalling_firm": "Pharmakon Pharmaceuticals", "address_1": "14450 Getz Rd", "address_2": "N/A", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States: TX, IL, MD, IN", "recall_number": "D-1566-2014", "product_description": "Midazolam HCl 1 mg/ml in 0.9% Sodium Chloride in 50 mL and 100 mL IV bag, Rx Only.  Labeled A) 50 mL, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd., Noblesville, IN 46060. NDC#: 45183-0989-41.  B) 100 mL, Pharmakon Pharmaceuticals, 14450 Getz Rd., Noblesville, IN 888-660-6715. NDC#: 45183-0796-48.", "product_quantity": "10/50 mL bags, 40/100 mL bags", "reason_for_recall": "Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.", "recall_initiation_date": "20140421", "center_classification_date": "20140826", "termination_date": "20141203", "report_date": "20140903", "code_info": "A) Lot #: E21294DK1C; Exp Date: 05/22/2014  B) Lot #: E21294DK3C; Exp Date: 06/08/2014"}, {"status": "Terminated", "city": "Aston", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67860", "recalling_firm": "Nova Products, Inc.", "address_1": "5 Mount Pleasant Rd", "address_2": "N/A", "postal_code": "19014-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide to retailers and distributors", "recall_number": "D-1600-2014", "product_description": "Xzen 1200, 750 mg, six capsules per bottle, Distributed by: xzen, City of Los Angeles, CA 90012", "product_quantity": "Unknown", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling Xzen 1200 because FDA laboratory analysis determined they contain undeclared amounts of sildenafil and tadalafil, active ingredients of FDA-approved drugs used to treat erectile dysfunction.", "recall_initiation_date": "20140328", "center_classification_date": "20140918", "termination_date": "20150806", "report_date": "20140924", "code_info": "Lot# 13051012", "more_code_info": ""}, {"country": "United States", "city": "Saint Paul", "address_1": "2400 Pilot Knob Rd", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Fagron is recalling six lots due to the presence of mold.", "address_2": "", "product_quantity": "97 jars", "code_info": "Lot # 14C24-U04-018189; Exp. 03/17   Lot # 14C26-U02-018214; Exp. 03/17", "center_classification_date": "20140730", "distribution_pattern": "Nationwide and Australia", "state": "MN", "product_description": "Fagron, Pentravan Base 2.5 Kg, Article number:  802486.  RX only, For prescription compounding, Oil-in-water emulsion, PLO gel alternative, Preserved and fragrance-free, Manufactured by; Fagron, Inc. 2400 Pilot Knob Rd, St. Paul, MN 55120 NDC 51552-0919-8.", "report_date": "20140806", "classification": "Class II", "openfda": {}, "recalling_firm": "Fagron, Inc", "recall_number": "D-1497-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "68896", "termination_date": "20141021", "more_code_info": "", "recall_initiation_date": "20140724", "postal_code": "55120-1118", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Clive", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68626", "recalling_firm": "Medical Supply Liquidators Llc", "address_1": "10500 Hickman Rd Ste F", "address_2": "N/A", "postal_code": "50325-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.", "recall_number": "D-1523-2014", "product_description": "Vitamin B6 Pyridoxine HCL for Injection USP, 100 mg/ml,  Sterile, for IM or Deep SQ Use, Multiple Dose 30 ml vial, manufactured by: CB Inc. for Sunshine Labs, www. sunshinelabs.us.", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer", "recall_initiation_date": "20140625", "center_classification_date": "20140806", "termination_date": "20170314", "report_date": "20140813", "code_info": "All lot numbers and exp dates"}, {"status": "Terminated", "city": "Noblesville", "state": "IN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68191", "recalling_firm": "Pharmakon Pharmaceuticals", "address_1": "14450 Getz Rd", "address_2": "N/A", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States: TX, IL, MD, IN", "recall_number": "D-1568-2014", "product_description": "Atropine Sulfate 0.4 mg/ml Injection, USP, Total Dosage 0.8 mg per 2 mL, 3 mL pre-filled syringe, Rx Only.  Pharmakon Pharmaceuticals, Inc., 14450 Getz Road, Noblesville, IN.  NDC: 45183-0105-78.", "product_quantity": "5 Syringes", "reason_for_recall": "Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.", "recall_initiation_date": "20140421", "center_classification_date": "20140826", "termination_date": "20141203", "report_date": "20140903", "code_info": "Lot #: E0333282R; Exp: 7/13/2014"}, {"status": "Terminated", "city": "Edison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68793", "recalling_firm": "Daiichi Sankyo Pharma Development", "address_1": "399 Thornall St", "address_2": "", "postal_code": "08837-2236", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1508-2014", "product_description": "Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/25 mg, 30 and 90 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-107-30 and NDC 65597-107-90", "product_quantity": "", "reason_for_recall": "Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.", "recall_initiation_date": "20140712", "center_classification_date": "20140731", "termination_date": "20150316", "report_date": "20140806", "code_info": "30 count/Lot #0002108  Exp - 12/31/2016;   90 count/Lot #0002078  Exp - 12/31/2016", "more_code_info": ""}, {"country": "United States", "city": "Oklahoma City", "address_1": "755 Research Pkwy Ste 150", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.", "address_2": "", "product_quantity": "", "code_info": "all lot codes 30 ml and 50 ml", "center_classification_date": "20140729", "distribution_pattern": "Nationwide", "state": "OK", "product_description": "Dermamedics Complexion Repair Topical Rehydrating Emulsion in 50 ml and 30 ml containers in the Dermamedics Complexion Repair Acne Treatment System Kit with SKU numbers of DM 1013 and DM 1025, respectively; Therametics Complexion Repair Topical Rehydrating Emulsion which was distributed in 50 ml containers with a SKU number of CR002 and in 50 ml containers in the Therametics Complexion Repair Acne Treatment System Kit with a SKU number of CR1005; and in 30 ml containers in the Therametics Complexion Repair Acne Travel Kit with a SKU number of CR1007.", "report_date": "20140806", "classification": "Class II", "openfda": {}, "recalling_firm": "Dermamedics, L.L.C.", "recall_number": "D-1494-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67247", "termination_date": "20170314", "more_code_info": "", "recall_initiation_date": "20140110", "postal_code": "73104-3621", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lewis Center", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076899"], "brand_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "generic_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "manufacturer_name": ["Amneal Pharmaceuticals of New York LLC"], "product_ndc": ["53746-271", "53746-272"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SULFAMETHOXAZOLE", "TRIMETHOPRIM"], "rxcui": ["198334", "198335"], "spl_id": ["bc5fe496-071b-4c25-95da-14c6c561e79e"], "spl_set_id": ["3233c54d-484d-4550-b172-db8af47d1b7f"], "package_ndc": ["53746-271-50", "53746-271-01", "53746-271-05", "53746-271-10", "53746-272-11", "53746-272-24", "53746-272-01", "53746-272-02", "53746-272-05"], "is_original_packager": [true], "upc": ["0353746271013", "0353746272010"], "nui": ["N0000175489", "N0000000191", "N0000187062", "N0000187061", "N0000175504", "M0020790", "N0000185504"], "pharm_class_epc": ["Dihydrofolate Reductase Inhibitor Antibacterial [EPC]", "Sulfonamide Antimicrobial [EPC]"], "pharm_class_moa": ["Dihydrofolate Reductase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "pharm_class_cs": ["Sulfonamides [CS]"], "unii": ["AN164J8Y0X", "JE42381TNV"]}, "product_type": "Drugs", "event_id": "64611", "recalling_firm": "Shamrock Medical Solutions Group LLC", "address_1": "741 Radio Dr", "address_2": "", "postal_code": "43035-7134", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Product was shipped to the following states: CO, MA, OH, TX & WY.", "recall_number": "D-1450-2014", "product_description": "Sulfamethoxazole and Trimethoprim Tablets, 800 mg/160 mg, DOUBLE STRENGTH, Rx, packaged and labeled to contain Sulfamethoxazole and Trimethoprim Tablets, 400 mg/80 mg, Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfg: Amneal/Interpharm, NDC 53746-272-01", "product_quantity": "284/800 mg tablets", "reason_for_recall": "Labeling: Label Mix up; product labeled to contain Sulfamethoxazole and Trimethoprim Tablets, 400 mg/80 mg instead of Sulfamethoxazole and Trimethoprim Tablets, 800 mg/160 mg", "recall_initiation_date": "20110927", "center_classification_date": "20140723", "termination_date": "20140731", "report_date": "20140730", "code_info": "Lot 00288N, Use By: 9/15/2012, NDC 53746-272-01", "more_code_info": ""}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Suite 200", "reason_for_recall": "Lack of Assurance of Sterility: Firm received fentanyl from a supplier who recalled it  because fliptop vial crimps were loose or missing.", "address_2": "", "product_quantity": "12 bags", "code_info": "Lot 7250-0 Exp. 08/14", "center_classification_date": "20140821", "distribution_pattern": "Texas and Georgia", "state": "TX", "product_description": "fentaNYL 200 mcg/100 mL (2 mcg/mL) and Ropivacaine 0.2% in 0.9% Sodium Chloride 100mL, in flexable bag,  COMPOUNDED DRUG   For Institutional or Office Use Only--Not for Resale   Federal Law Prohibits Dispensing without Prescription  Healix Infusion Therapy, Inc., at 866-299-4826, 1075 West Park One Drive, Suite 200, Sugar Land, Texas, 77478, NDC 75901-8007-02", "report_date": "20140827", "classification": "Class II", "openfda": {}, "recalling_firm": "Healix Infusion Therapy, Inc.", "recall_number": "D-1553-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "69056", "termination_date": "20150825", "more_code_info": "", "recall_initiation_date": "20140627", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Columbus", "address_1": "2550 John Glenn Ave", "reason_for_recall": "Labeling: Label Mix-Up: Some cartons of AHP Ibuprofen Tablets, USP, 600mg, lot #142588 that contain blister cards filled with Ibuprofen tablets, 600mg drug product, were found to be mis-labeled  with blister card print identifying the product as AHP Oxcarbazepine Tablets, 300mg, lot #142544.", "address_2": "Suite A", "product_quantity": "59,200 tablets", "code_info": "Lot #142544, Exp 02/2016", "center_classification_date": "20140918", "distribution_pattern": "Nationwide and Puerto Rico", "state": "OH", "product_description": "Oxcarbazepine Tablets, 300 mg, 100 tablets per carton (10 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, OH 43217, NDC 62584-143-01", "report_date": "20140924", "classification": "Class I", "openfda": {}, "recalling_firm": "American Health Packaging", "recall_number": "D-1590-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68779", "termination_date": "20150803", "more_code_info": "", "recall_initiation_date": "20140701", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA077908"], "brand_name": ["PROPOFOL"], "generic_name": ["PROPOFOL"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4699", "0409-6010"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PROPOFOL"], "rxcui": ["1808217", "1808222", "1808224"], "spl_id": ["d55c0318-811d-4624-aa0c-456182f7b019"], "spl_set_id": ["28d7ba00-f824-4e55-139a-03f509c099db"], "package_ndc": ["0409-4699-50", "0409-4699-30", "0409-4699-53", "0409-4699-33", "0409-4699-54", "0409-4699-24", "0409-6010-02", "0409-6010-25"], "is_original_packager": [true], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["YI7VU623SF"]}, "product_type": "Drugs", "event_id": "67936", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1547-2014", "product_description": "Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), For I.V. Administration, Rx Only, 20 mL vial, Contains Benzyl Alcohol, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-4699-30", "product_quantity": "844,300 vials", "reason_for_recall": "Presence of Particulate Matter: A glass defect was found on the interior neck of the vial during a retain sample inspection where the glass vial contained visible embedded metallic particulate and free floating metallic particulates were also found in solution.", "recall_initiation_date": "20140402", "center_classification_date": "20140820", "termination_date": "20150529", "report_date": "20140827", "code_info": "Lot #s: 29-614-DJ, 29-615-DJ, 29-616-DJ, 29-617-DJ, 29-628-DJ, 29-629-DJ, 29-630-DJ, Exp 05/01/2015", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "10 units", "code_info": "Rx # 29175, Exp 05/21/14; Rx # 28830, Exp 05/17/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Cubicin 543 mg/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29175, Discard After 05/21/14; Rx # 28830, Discard After 05/17/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1476-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx # 27767, Exp 05/23/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Desferal 2 gm/8 mL Sterile Water, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 27767, Discard After 05/23/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1464-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Broomfield", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA074112"], "brand_name": ["ALPRAZOLAM"], "generic_name": ["ALPRAZOLAM"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-1061", "0781-1077", "0781-1079", "0781-1089"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ALPRAZOLAM"], "rxcui": ["197321", "197322", "308047", "308048"], "spl_id": ["4c8c7366-aa3b-4124-9d64-67fb0ead6e15"], "spl_set_id": ["d9b0e228-17cf-40d7-b62e-5050311c571c"], "package_ndc": ["0781-1061-01", "0781-1061-05", "0781-1061-10", "0781-1077-01", "0781-1077-05", "0781-1077-10", "0781-1079-01", "0781-1079-05", "0781-1079-10", "0781-1089-01", "0781-1089-05"], "is_original_packager": [true], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["YU55MQ3IZY"]}, "product_type": "Drugs", "event_id": "68900", "recalling_firm": "Sandoz Incorporated", "address_1": "2555 W Midway Blvd", "address_2": "", "postal_code": "80020-1632", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1509-2014", "product_description": "Alprazolam Tablets, USP, 0.25mg, Rx only, 1000 tablets, Sandoz Inc., Princeton, NJ --- NDC 0781-1061-10", "product_quantity": "1,332 bottles", "reason_for_recall": "Presence of Foreign Substance; tablets may contain stainless steel metal particulates", "recall_initiation_date": "20140725", "center_classification_date": "20140731", "termination_date": "20150205", "report_date": "20140806", "code_info": "Lot EJ9591", "more_code_info": ""}, {"status": "Terminated", "city": "Edison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68793", "recalling_firm": "Daiichi Sankyo Pharma Development", "address_1": "399 Thornall St", "address_2": "", "postal_code": "08837-2236", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1504-2014", "product_description": "Tribenzor Tablets (olmesartan medoxomil/amlodipine/hydrochlorothiazide), 40 mg/5 mg*/25 mg 30 count bottles, Rx Only  Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-116-30", "product_quantity": "", "reason_for_recall": "Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping", "recall_initiation_date": "20140712", "center_classification_date": "20140731", "termination_date": "20150316", "report_date": "20140806", "code_info": "Lot #211836 Exp - 11/30/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021897"], "brand_name": ["VIVITROL"], "generic_name": ["NALTREXONE"], "manufacturer_name": ["Alkermes, Inc."], "product_ndc": ["65757-300", "65757-301"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["637213", "637216"], "spl_id": ["908a42b5-e168-42ca-9421-0f5f2288b7e2"], "spl_set_id": ["cd11c435-b0f0-4bb9-ae78-60f101f3703f"], "package_ndc": ["65757-300-01", "65757-302-02", "65757-304-03", "65757-301-01", "65757-303-02", "65757-305-03"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "67838", "recalling_firm": "Alkermes, Inc.", "address_1": "852 Winter St", "address_2": "N/A", "postal_code": "02451-1420", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1556-2014", "product_description": "VIVITROL (naltrexone for extended-release injectable suspension);  380 mg vial NDC 65757-300-01; RX Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451.", "product_quantity": "4,364 vials", "reason_for_recall": "Customer complaints for failure to deliver the dose.", "recall_initiation_date": "20140304", "center_classification_date": "20140822", "termination_date": "20141222", "report_date": "20140903", "code_info": "Batch Number: 412-3732AA; expiration date 07/2016 (NDC# 65757-302-02; Kit Pacaging Lot Number: 2013-021; expiration date 07/2016 (NDC# 65757-300-01."}, {"status": "Terminated", "city": "Suffern", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "68815", "recalling_firm": "Novartis Pharmaceuticals Corp.", "address_1": "25 Old Mill Rd", "address_2": "N/A", "postal_code": "10901-4106", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1516-2014", "product_description": "Cataflam (diclofenac potassium) tablets, 50 mg, 100-count bottles, Rx only, Manufactured by: Patheon Inc., Whitby Operations, Ontario, Canada L1N 5Z5; Distributed by: Novartis Pharmaceuticals Corp., East Hanover, New Jersey  07936; NDC 0078-0436-05, UPC 3 0078-0436-05 2.", "product_quantity": "50 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegible to pharmacists and consumers.", "recall_initiation_date": "20140730", "center_classification_date": "20140806", "termination_date": "20141205", "report_date": "20140813", "code_info": "Lot # PKTS, Exp 01/17"}, {"status": "Terminated", "city": "Edison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68793", "recalling_firm": "Daiichi Sankyo Pharma Development", "address_1": "399 Thornall St", "address_2": "", "postal_code": "08837-2236", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1502-2014", "product_description": "Benicar Tablets (olmesartan medoxomil) 20 mg, 30 and 90 count, Rx Only Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-103-30 and  NDC 65597-103-90", "product_quantity": "262 bottles", "reason_for_recall": "Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping", "recall_initiation_date": "20140712", "center_classification_date": "20140731", "termination_date": "20150316", "report_date": "20140806", "code_info": "30 count - Lot #0002055  Exp - 11/30/2016;   90 count - Lot #0002063  Exp - 12/31/2016", "more_code_info": ""}, {"country": "United States", "city": "Concord", "address_1": "7101 Weddington Rd NW", "reason_for_recall": "Failed Dissolution Specification; at the 12 month time interval.", "address_2": "", "product_quantity": "1,511,250 tablets", "code_info": "Lot 0093943", "center_classification_date": "20140728", "distribution_pattern": "Nationwide", "state": "NC", "product_description": "Aspirin DR Enteric Coated Tablets, USP 325 mg, UD 750 tablets (25x30), Dist. By: McKesson Packaging Services a business unit of McKesson Corporation, concord, NC", "report_date": "20140806", "classification": "Class III", "openfda": {}, "recalling_firm": "Mckesson Packaging Services", "recall_number": "D-1483-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "68652", "termination_date": "20170427", "more_code_info": "", "recall_initiation_date": "20140619", "postal_code": "28027-3412", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Aston", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67860", "recalling_firm": "Nova Products, Inc.", "address_1": "5 Mount Pleasant Rd", "address_2": "N/A", "postal_code": "19014-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide to retailers and distributors", "recall_number": "D-1603-2014", "product_description": "MOJO RISEN ,670 mg,  2 capsule per pouch, Distributed by: Mojo Risen, LLC, Springville, UT 84663", "product_quantity": "Unknown", "reason_for_recall": "Marketed Without an Approved NDA/ANDA; Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling AFRICAN BLACK ANT because FDA laboratory analysis determined they contain undeclared amounts of sildenafil an active ingredient of FDA-approved drugs used to treat erectile dysfunction.", "recall_initiation_date": "20140328", "center_classification_date": "20140918", "termination_date": "20150806", "report_date": "20140924", "code_info": "Lot# 10081359", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019115"], "brand_name": ["FENTANYL CITRATE"], "generic_name": ["FENTANYL CITRATE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-9094", "0409-9093"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["FENTANYL CITRATE"], "rxcui": ["1735003", "1735004", "1735006", "1735007", "1735008", "1735013"], "spl_id": ["e4b31fdd-00af-416d-b14e-dbac0c83da97"], "spl_set_id": ["bfa8018a-4cbc-434b-e09e-782872b0340a"], "package_ndc": ["0409-9093-37", "0409-9093-32", "0409-9093-45", "0409-9093-35", "0409-9093-41", "0409-9093-36", "0409-9093-31", "0409-9093-38", "0409-9094-12", "0409-9094-22", "0409-9094-18", "0409-9094-25", "0409-9094-17", "0409-9094-28", "0409-9094-16", "0409-9094-31", "0409-9094-41", "0409-9094-61"], "is_original_packager": [true], "unii": ["MUN5LYG46H"]}, "product_type": "Drugs", "event_id": "68751", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1433-201", "product_description": "Fentanyl Citrate Injection, USP, 2500 mcg Fentanyl/50 mL, C-II, (50 mcg/mL), 50 mL Single-dose Fliptop Vial, Rx only.  Hospira, Inc., Lake Forest, IL 60045. NDC: 0409-9094-61.", "product_quantity": "47,400 vials", "reason_for_recall": "Lack of Assurance of Sterility: Fliptop vial crimps are loose or missing.", "recall_initiation_date": "20140627", "center_classification_date": "20140714", "termination_date": "20150909", "report_date": "20140723", "code_info": "Lot #: 39474DK, Expiry: 03/01/2016."}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "68639", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide (Continental USA and Puerto Rico).  A portion of the bulk lot was supplied to Pfizer Germany for packaging into blisters for non- USA market.  One of these lots in Germany was placed in stability having acceptable results, therefore are not part of the recall scope.  Only the product distributed within US/PR market (bottles) is in the scope of this recall.", "recall_number": "D-1485-2014", "product_description": "Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New York, NY 10017,  NDC 0049-2710-30", "product_quantity": "22,461 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.", "recall_initiation_date": "20140619", "center_classification_date": "20140728", "termination_date": "20150603", "report_date": "20140806", "code_info": "Lot # V130822; Exp 01/15", "more_code_info": ""}, {"status": "Terminated", "city": "Edison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68793", "recalling_firm": "Daiichi Sankyo Pharma Development", "address_1": "399 Thornall St", "address_2": "", "postal_code": "08837-2236", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1506-2014", "product_description": "Benicar Tablets (olmesartan medoxomil) 40 mg, 30 and 90 count, Rx Only Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-104-30 and 65597-104-90", "product_quantity": "", "reason_for_recall": "Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.", "recall_initiation_date": "20140712", "center_classification_date": "20140731", "termination_date": "20150316", "report_date": "20140806", "code_info": "30 count - Lot #0002096  Exp - 12/31/2016;   90 count - Lot #0002058  Exp -12/31/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020849"], "brand_name": ["PROSOL"], "generic_name": ["VALINE, LYSINE, HISTIDINE, ISOLEUCINE, LEUCINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0499"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ALANINE", "ARGININE", "ASPARTIC ACID", "GLUTAMIC ACID", "GLYCINE", "HISTIDINE", "ISOLEUCINE", "LEUCINE", "LYSINE ACETATE", "METHIONINE", "PHENYLALANINE", "PROLINE", "SERINE", "THREONINE", "TRYPTOPHAN", "TYROSINE", "VALINE"], "rxcui": ["801133", "801136"], "spl_id": ["ee240b46-c2a9-42e0-8750-a5a554becea3"], "spl_set_id": ["cc2ace81-5881-43f1-ba94-41b674adc2fc"], "package_ndc": ["0338-0499-06"], "is_original_packager": [true], "nui": ["N0000175780", "M0000922"], "pharm_class_epc": ["Amino Acid [EPC]"], "pharm_class_cs": ["Amino Acids [CS]"], "unii": ["OF5P57N2ZX", "94ZLA3W45F", "30KYC7MIAI", "3KX376GY7L", "TE7660XO1C", "4QD397987E", "04Y7590D77", "GMW67QNF9C", "TTL6G7LIWZ", "AE28F7PNPL", "47E5O17Y3R", "9DLQ4CIU6V", "452VLY9402", "2ZD004190S", "8DUH1N11BX", "42HK56048U", "HG18B9YRS7"]}, "product_type": "Drugs", "event_id": "68963", "recalling_firm": "Baxter Healthcare Corp", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1542-2014", "product_description": "ProSol - sulfite-free (Amino Acid) Injection, 20%, 2000 mL VIAFLEX container bag, Rx only, Baxter Healthcare Corporation, Clinitec Nutrition Division, Deerfield, IL  60015 USA, Product Code 2B6186, NDC 0338-0499-06.", "product_quantity": "6,204 bags", "reason_for_recall": "Presence of Particulate Matter: identification of particulates in a retention sample that have been identified as a mixture of the amino acid leucine and inorganic material (containing iron, silicone and chlorine).", "recall_initiation_date": "20140804", "center_classification_date": "20140818", "termination_date": "20150610", "report_date": "20140827", "code_info": "Lot #: P306225, Exp 08/14", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "60 units", "code_info": "Rx # 29082 Exp. 5/19/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Unasyn (ampicillin/sulbactam) 1.5 gm/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29082, Discard After 05/19/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1463-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "12 units", "code_info": "Rx # 29157, Exp 5/19/14; Rx # 29097, Exp 5/20/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Invanz  (ertapenem)1 gm/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29157, Discard After 05/19/14; Rx # 29097, Discard After 05/20/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1460-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA075863"], "brand_name": ["KARIVA"], "generic_name": ["DESOGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-9050"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["248310", "249357", "748797", "759743", "762001"], "spl_id": ["ad406427-c901-4f7c-9b4f-68bd0667593d"], "spl_set_id": ["7b11e11f-6977-4109-b9bd-a066e5d1278a"], "package_ndc": ["0555-9050-79", "0555-9050-58"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "68610", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1438-2014", "product_description": "Kariva (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets    0.15 mg/0.02 mg and 0.01 mg, 6 Cyclic dispensers X 28 tablets, Rx only,  Teva Pharmaceuticals, Sellersville, PA NDC 0555-9050-58", "product_quantity": "1125 blister packs", "reason_for_recall": "Failed Impurities/Degradation Specifications: out of specification impurity test results.", "recall_initiation_date": "20140617", "center_classification_date": "20140717", "termination_date": "20150309", "report_date": "20140723", "code_info": "Lot 33805325A, Exp.11/14"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "14 units", "code_info": "Rx # 28503, Exp 02/27/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Tobramycin 300 mg/7.5 mL Syringe (for Neb), Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 28503, Discard After 02/27/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1471-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "14 units", "code_info": "Rx # 29185, Exp 05/23/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Vancomycin 1.25 gm/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29185, Discard After 05/23/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1475-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "21 units", "code_info": "Rx # 28837, Exp 04/11/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Cefazolin 1 gm/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 28837, Discard After 04/11/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1466-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68532", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "37497 Schoolcraft Rd", "address_2": "N/A", "postal_code": "48150-1007", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Michigan and Wisconsin", "recall_number": "D-1562-2014", "product_description": "LOW Potassium Cardioplegia 792 mL, Rx Only, Central Admixture Pharmacy Services, Inc., Livonia, MI 48150", "product_quantity": "4 doses", "reason_for_recall": "Non Sterility; microbial contamination identified as Aspergillus species", "recall_initiation_date": "20140528", "center_classification_date": "20140825", "termination_date": "20140919", "report_date": "20140903", "code_info": "Lot # 13-920739-01 through Lot # 13-920739-04 (4 total doses) EXP 21 Jun 2014"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67135", "recalling_firm": "Abrams Royal Pharamacy", "address_1": "8220 Abrams Rd", "address_2": "N/A", "postal_code": "75231-1402", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and to Canada", "recall_number": "D-1564-2014", "product_description": "All Unexpired Sterile Drug Products, compounded by Abrams Royal Pharmacy Inc., Dallas, TX", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20131219", "center_classification_date": "20140825", "termination_date": "20161007", "report_date": "20140903", "code_info": "All unexpired lots of sterile drug products"}, {"country": "United States", "city": "Oklahoma City", "address_1": "755 Research Pkwy Ste 150", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.", "address_2": "", "product_quantity": "", "code_info": "all lot codes", "center_classification_date": "20140729", "distribution_pattern": "Nationwide", "state": "OK", "product_description": "Dermamedics Post Procedure Cream 1 oz. containers in the Dermamedics Post-Laser Treatment System with a SKU number of DM 1019", "report_date": "20140806", "classification": "Class II", "openfda": {}, "recalling_firm": "Dermamedics, L.L.C.", "recall_number": "D-1492-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67247", "termination_date": "20170314", "more_code_info": "", "recall_initiation_date": "20140110", "postal_code": "73104-3621", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Edison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68793", "recalling_firm": "Daiichi Sankyo Pharma Development", "address_1": "399 Thornall St", "address_2": "", "postal_code": "08837-2236", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1501-2014", "product_description": "Azor Tablets (amlodipine and olmesartan medoxomil) 10 mg*/40 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc. Parsippany, NJ 07054  NDC 65597-113-30", "product_quantity": "5 bottles", "reason_for_recall": "Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping", "recall_initiation_date": "20140712", "center_classification_date": "20140731", "termination_date": "20150316", "report_date": "20140806", "code_info": "Lot #213655B Exp - 12/31/2017", "more_code_info": ""}, {"status": "Terminated", "city": "Melville", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "68683", "recalling_firm": "Fougera Pharmaceuticals  Inc.", "address_1": "60 Baylis Rd", "address_2": "N/A", "postal_code": "11747-3838", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1440-2014", "product_description": "Triamcinolone Acetonide Lotion USP, 0.1%, 60 mL Bottle, Rx Only, For Dermatologic Use Only, Not for Ophthalmic Use, E. Fougera & Co, A Division of Fougera Pharmaceuticals Inc., Melville, New York, 11747, NDC 0168-0337-60.", "product_quantity": "111,388 Bottles", "reason_for_recall": "Failed PH Specifications: It has been determined that the pH of the lots recalled, may not meet specification at expiry.", "recall_initiation_date": "20140703", "center_classification_date": "20140717", "termination_date": "20151207", "report_date": "20140723", "code_info": "Lot(s): 497R, 498R, Exp 01/2015; 635R, 636R, Exp 03/2015;  850R, Exp 04/2015; 073S, Exp 05/2015; 074S, Exp 06/2015."}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "21 units", "code_info": "Rx # 29186, Exp 05/22/14; Rx # 29010, Exp 05/22/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Vancomycin 1 gm/100 mL 0.9%NS,Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29186, Discard After 05/22/14; Rx # 29010, Discard After 05/22/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1472-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "11 units", "code_info": "Rx # 28879, Exp 05/21/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Cefepime 2 gm/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 28879, Discard After 05/21/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1481-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "5 units", "code_info": "Rx # 29150, Exp 05/17/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Ceftriaxone 2 gm/100 mL D5W, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29150, Discard After 05/17/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1480-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Lewis Center", "address_1": "741 Radio Dr", "reason_for_recall": "Labeling: Label Mix up; product labeled to contain Nebivolol tablets actually contained Pramipexole Dihydrochloride tablets", "address_2": "", "product_quantity": "99/500 mg tablets", "code_info": "Use by 12/14/2012, Lot# 002B90, NDC 16714-586-01", "center_classification_date": "20140723", "distribution_pattern": "Product was shipped to the following states: CO, MA, OH, TX & WY.", "state": "OH", "product_description": "Pramipexole Dihydrochloride Tablets, 0.5 mg, Rx, packaged and labeled to contain Nebivolol tablets, Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfg: Northstar Rx, Memphis, TN   NDC 16714-586-01", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Shamrock Medical Solutions Group LLC", "recall_number": "D-1449-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "64611", "termination_date": "20140731", "more_code_info": "", "recall_initiation_date": "20110927", "postal_code": "43035-7134", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Oklahoma City", "address_1": "755 Research Pkwy Ste 150", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.", "address_2": "", "product_quantity": "", "code_info": "all lot codes", "center_classification_date": "20140729", "distribution_pattern": "Nationwide", "state": "OK", "product_description": "Dermamedics Calm and Correct Serum, 2 oz. containers with a SKU number of BB10062 and 4 oz. containers with a SKU number of BB10068.", "report_date": "20140806", "classification": "Class II", "openfda": {}, "recalling_firm": "Dermamedics, L.L.C.", "recall_number": "D-1491-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67247", "termination_date": "20170314", "more_code_info": "", "recall_initiation_date": "20140110", "postal_code": "73104-3621", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Deerfield", "address_1": "1 Baxter Pkwy", "reason_for_recall": "Presence of Particulate Matter; blue polyisoprene shavings found inside the bag port tubes", "address_2": "", "product_quantity": "4,200 containers", "code_info": "Lot C931923, exp 8/31/2015", "center_classification_date": "20140821", "distribution_pattern": "Nationwide", "state": "IL", "product_description": "0.9 % Sodium Chloride Injection, USP, 1000 mL in VIAFLEX Plastic Container, Baxter Healthcare Corporation, Deerfield, IL 60015", "report_date": "20140827", "classification": "Class I", "openfda": {}, "recalling_firm": "Baxter Healthcare Corp.", "recall_number": "D-1550-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "68089", "termination_date": "20150629", "more_code_info": "", "recall_initiation_date": "20140512", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Clive", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68626", "recalling_firm": "Medical Supply Liquidators Llc", "address_1": "10500 Hickman Rd Ste F", "address_2": "N/A", "postal_code": "50325-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.", "recall_number": "D-1530-2014", "product_description": "Lipo 8 Injection USP 200 mg/ml, packaged in 30 ml vials, Sterile, Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us.", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer", "recall_initiation_date": "20140625", "center_classification_date": "20140806", "termination_date": "20170314", "report_date": "20140813", "code_info": "All lot numbers and exp dates"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA070583"], "brand_name": ["BUPIVACAINE HYDROCHLORIDE"], "generic_name": ["BUPIVACAINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1159", "0409-1160", "0409-1162", "0409-1163", "0409-1165", "0409-9043", "0409-9046", "0409-9045", "0409-9042"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["EPIDURAL", "INFILTRATION", "INTRACAUDAL", "PERINEURAL"], "substance_name": ["BUPIVACAINE HYDROCHLORIDE"], "rxcui": ["1012377", "1012384", "1012396", "1012404", "1672917", "1672919", "1724786", "1724787", "1724880", "1724884", "1725078", "1725082", "1867594", "1867596"], "spl_id": ["3c6a5b9f-4ea0-4ccd-a384-a90e4ad379e7"], "spl_set_id": ["02a845c3-4521-4926-e397-25ab536e7cf6"], "package_ndc": ["0409-1159-18", "0409-1159-01", "0409-1159-19", "0409-1159-02", "0409-1160-18", "0409-1160-01", "0409-1162-18", "0409-1162-01", "0409-1162-19", "0409-1162-02", "0409-1163-18", "0409-1163-01", "0409-1165-18", "0409-1165-01", "0409-1165-19", "0409-1165-02", "0409-9043-11", "0409-9043-01", "0409-9046-11", "0409-9046-01", "0409-9045-11", "0409-9045-01", "0409-9045-16", "0409-9045-17", "0409-9042-11", "0409-9042-01", "0409-9042-16", "0409-9042-17"], "is_original_packager": [true], "unii": ["7TQO7W3VT8", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "69247", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1588-2014", "product_description": "Bupivacaine HCl Inj., USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative-Free, For Nerve Block, Caudal, and Epidural Anesthesia, Not for Spinal Anesthesia, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1162-02", "product_quantity": "75,000 vials", "reason_for_recall": "Presence of Particulate Matter:  A confirmed customer complaint reported the presence of a brown, rust-colored particle embedded at the bottom of the glass vial.", "recall_initiation_date": "20140904", "center_classification_date": "20140917", "termination_date": "20150723", "report_date": "20140924", "code_info": "LOT 37-268-DK; Exp: 1JAN2016", "more_code_info": ""}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "68610", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1437-2014", "product_description": "Mircette (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets   0.15 mg/0.02 mg and 0.01 mg, 6 Cyclic dispensers X 28 tablets, Rx only Teva Pharmaceuticals, USA, Sellersville, PA. NDC 51285-114-58", "product_quantity": "984 blister packs", "reason_for_recall": "Failed Impurities/Degradation Specifications: out of specification impurity test results.", "recall_initiation_date": "20140617", "center_classification_date": "20140717", "termination_date": "20150309", "report_date": "20140723", "code_info": "Lot 33805507A, Exp. date 11/14"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022057"], "brand_name": ["ENDOMETRIN"], "generic_name": ["PROGESTERONE"], "manufacturer_name": ["Ferring Pharmaceuticals Inc."], "product_ndc": ["55566-6500"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["VAGINAL"], "substance_name": ["PROGESTERONE"], "rxcui": ["725094", "725098"], "spl_id": ["8749cf61-2e35-473a-bfe5-49d342a17ff3"], "spl_set_id": ["2ba50fa9-b349-40cb-9a4b-1af8faa4ec09"], "package_ndc": ["55566-6500-1", "55566-6500-2", "55566-6500-3"], "is_original_packager": [true], "nui": ["M0017672", "N0000175601"], "pharm_class_cs": ["Progesterone [CS]"], "pharm_class_epc": ["Progesterone [EPC]"], "unii": ["4G7DS2Q64Y"]}, "product_type": "Drugs", "event_id": "66604", "recalling_firm": "Ferring Pharmaceuticals Inc", "address_1": "4 Gatehall Dr Fl 3rd", "address_2": "", "postal_code": "07054-4518", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1426-2014", "product_description": "ENDOMETRIN (progesterone) Vaginal Insert 100 mg USP, 21 inserts, Rx Only, Manufactured for: Ferring Pharmaceuticals Inc. Parsippany, NJ 07054 ---- NDC 55566-6500-3", "product_quantity": "72,046 cartons", "reason_for_recall": "Discoloration; due to prolonged heat exposure.", "recall_initiation_date": "20130919", "center_classification_date": "20140709", "termination_date": "20150219", "report_date": "20140716", "code_info": "Lot Number:Expiry Date - 0804.182B-1:07/14; 0804.183B-1:07/14; 0804.185A-1:08/14; 0804.186B-1:08/14; 0804.187B-1:08/14; 0804.210A-1:12/14; 0804.212A-1:12/14; 0804.213A-1:12/14; 0804.214A-1:12/14; 0804.216B-1:12/14; 0804.223B-1:02/15 0804.225B-1:03/15", "more_code_info": ""}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "68645", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1557-2014", "product_description": "Diltiazem HCl Extended Release Capsules, USP 120 mg, 500 count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505. NDC 0378-5220-05.", "product_quantity": "2,658 Bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound  obtained during routine stability testing.", "recall_initiation_date": "20140619", "center_classification_date": "20140822", "termination_date": "20150723", "report_date": "20140903", "code_info": "Lot 3040063 Exp. 07/14"}, {"status": "Terminated", "city": "Detroit", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68786", "recalling_firm": "Caraco Pharmaceutical Laboratories, Ltd.", "address_1": "1150 Elijah McCoy Dr", "address_2": "N/A", "postal_code": "48202-3344", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1511-2014", "product_description": "Cephalexin Capsules, USP, 500 mg, packaged in a) 100-count bottles (NDC 62756-294-88) and b) 500-count bottles (NDC 62756-294-13), Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., Acme Plaza, Andheri-Kurla Road, Andheri (East), Mumbai-400 059, India.", "product_quantity": "a) 43,585 bottles; b) 296,968 bottles", "reason_for_recall": "CGMP Deviations: These products are being recalled because they were manufactured with active pharmaceutical ingredients (APIs) that were not manufactured with good manufacturing practices.", "recall_initiation_date": "20140626", "center_classification_date": "20140801", "termination_date": "20150309", "report_date": "20140813", "code_info": "Lot #: a) AGL0058B, AGL0059B, AGL0060B, AGL0061B, Exp 06/14; AGL0062B, AGL0063B, AGL0064B, Exp 07/14; AGL0083B, AGL0084B, AGL0085B, AGL0086B, AGL0087B, AGL0088B, AGL0089B, AGL0090B, Exp 08/14; AGL0120B, AGL0121B, AGL0122B, AGL0123B, Exp 11/14; AGM0001B, AGM0002B, AGM0003B, AGM0004B, Exp 12/14; AGM0021B, AGM0022B, AGM0023B, AGM0024B, Exp 01/15; AGM0031B, AGM0032B, AGM0033B, AGM0034B, Exp 02/15; AGM0053B, AGM0054B, AGM0055B, AGM0056B, Exp 03/15; AGM0075B, AGM0076B, AGM0077B, AGM0078B, Exp 04/15; AGM0091B, AGM0092B, AGM0093B, AGM0094B, Exp 05/15; AGM0118B, AGM0119B, AGM0120B, AGM0121B, Exp 07/15; AGM0138B, AGM0144B, AGM0145B, AGM0146B, Exp 08/15; AGM0164B, AGM0165B, AGM0166B, Exp 09/15; b) AGL0065A, AGL0066A, AGL0067A, AGL0068A, AGL0069A, AGL0070A, AGL0071A, AGL0072A, AGL0073A, AGL0074A, AGL0075A, AGL0076A, Exp 07/14; AGL0077A, AGL0078A, AGL0079A, AGL0080A, AGL0081A, AGL0082A, AGL0091A, Exp 08/14; AGL0106A, AGL0107A, AGL0108A, AGL0109A, AGL0110A, AGL0111A, Exp 09/14; AGL0113A, AGL0114A, AGL0115A, AGL0116A, AGL0117A, AGL0118A, AGL0119A, Exp 10/14; AGL0124A, AGL0125A, AGL0126A, AGL0127A, AGL0128A, AGL0129A, AGL0130A, AGL0131A, AGL0132A, AGL0133A, AGL0134A, Exp 11/14; AGM0005A, AGM0006A, AGM0007A, AGM0008A, AGM0009A, AGM0010A, AGM0011A, AGM0012A, AGM0013A, AGM0014A, AGM0015A, AGM0016A, Exp 12/14; AGM0017A, AGM0018A, AGM0019A, AGM0020A, AGM0025A, AGM0026A, AGM0027A, AGM0028A, AGM0029A, AGM0030A, Exp 01/15; AGM0035A, AGM0036A, AGM0037A, AGM0038A, AGM0039A, AGM0040A, AGM0041A, AGM0042A, AGM0043A, AGM0044A, AGM0045A, AGM0046A, AGM0047A, AGM0048A, Exp 02/15; AGM0049A, AGM0050A, AGM0051A, AGM0052A, AGM0057A, AGM0058A, AGM0059A, AGM0060A, AGM0061A, AGM0062A, AGM0063A, AGM0064A, AGM0065A, AGM0066A, Exp 03/15; AGM0079A, AGM0080A, AGM0081A, AGM0082A, AGM0083A, AGM0084A, Exp 04/15; AGM0087A, AGM0088A, AGM0089A, AGM0090A, AGM0095A, AGM0096A, AGM0097A, AGM0098A, AGM0099A, Exp 05/15; AGM0100A, AGM0101A, AGM0102A, AGM0103A, AGM0104A, AGM0105A, AGM0106A, AGM0107A, AGM0108A, AGM0109A, AGM0110A, AGM0111A, AGM0112A, AGM0113A, AGM0114A, AGM0115A, AGM0116A, AGM0117A, AGM0122A, AGM0123A, AGM0124A, AGM0133A, AGM0134A, Exp Date:  2015-07-31; Lot #  AGM0135A, Exp Date:  2015-07-31; Lot #  AGM0136A, Exp 07/15; AGM0137A, AGM0139A, AGM0140A, AGM0141A, AGM0142A, AGM0143A, AGM0147A, AGM0148A, AGM0149A, AGM0150A, AGM0151A, AGM0152A, AGM0153A, AGM0154A, AGM0155A, AGM0156A, AGM0157A, Exp 08/15; AGM0167A, AGM0168A, Exp 09/15"}]